MMS Share Price | MAXIMUS, Inc. Stock Analysis & Recommendation

Q: How big is MAXIMUS, Inc.?

Market Cap: As of Jun 18, MAXIMUS, Inc. has a market capitalization of 3,902.20 million, categorizing it as a Small Cap company.Recent Quarterly Performance: For the latest four quarters, MAXIMUS, Inc. reported net sales of 5,395.26 million and a net profit of 300.02 million.Balance Sheet Snapshot: As of Sep 24, the company reported shareholder's funds of 1,842.82 million and total assets of 4,131.51 million.

Q: What does MAXIMUS, Inc. do?

Overview:MAXIMUS, Inc. provides business process services (BPS) to government health and human services agencies and operates in the Miscellaneous industry within the small-cap market.Financial Snapshot:Net Sales: 1,362 Million (Quarterly Results - Mar 2025)Net Profit: 97 Million (Quarterly Results - Mar 2025)Market cap: USD 3,902.20 Million (Small Cap)Key Metrics:P/E: 13.00Dividend Yield: 0.00%Debt Equity: 0.82Return on Equity: 18.06%Price to Book: 2.34Contact Details:Address: 1891 Metro Center Dr, RESTON VA: 20190-5287Tel: ['1 703 2518500', '1 703 2518637']Fax: 1 703 2518240Website: https://www.maximus.com/

Q: Is MAXIMUS, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for MAXIMUS, Inc. has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued, with a P/E ratio of 13, an EV to EBITDA of 8.13, and a PEG ratio of 0.35, suggesting that it may not be as undervalued as previously thought. In comparison to peers, Genpact Ltd. has a P/E of 14.38 and an EV to EBITDA of 10.34, while ADT, Inc. stands out with a lower P/E of 10.02 and an attractive valuation.In terms of recent performance, MAXIMUS has underperformed against the S&P 500 over the past year, returning -5.29% compared to the index's 14.08%, and has also lagged significantly over the longer term, with a 3-year return of 47.47% versus the S&P 500's 81.19%. This underperformance may reinforce the view that MAXIMUS is fairly valued rather than a compelling investment opportunity at this time.

Q: Is MAXIMUS, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for MAXIMUS, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, and the Bollinger Bands indicate a bullish stance, while the daily moving averages are mildly bullish. However, the KST shows a bearish monthly trend, and the Dow Theory presents a mildly bearish weekly perspective. The overall technical stance is mildly bullish, driven by the positive weekly MACD and Bollinger Bands.In terms of performance, MAXIMUS has outperformed the S&P 500 over the past week with a return of 2.98% compared to the S&P 500's 1.92%, but it has lagged behind over the longer periods, particularly in the 3-year and 5-year returns.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

147.33 k

Shareholding (Dec 2025)

FII

18.90%

Held by 163 FIIs

DII

16.1%

Held by 72 DIIs

Promoter

0.10%

How big is MAXIMUS, Inc.?

22-Jun-2025

As of Jun 18, MAXIMUS, Inc. has a market capitalization of 3,902.20 million, with net sales of 5,395.26 million and a net profit of 300.02 million over the latest four quarters.

View full answer

What does MAXIMUS, Inc. do?

22-Jun-2025

MAXIMUS, Inc. provides business process services to government health and human services agencies, with a market cap of approximately $3.9 billion and a net profit of $97 million as of March 2025. Key metrics include a P/E ratio of 13.00 and a return on equity of 18.06%.

View full answer

Who are in the management team of MAXIMUS, Inc.?

22-Jun-2025

As of March 2022, the management team of MAXIMUS, Inc. includes Peter Pond (Chairman), Bruce Caswell (CEO), Richard Montoni (Vice Chairman), and directors John Haley, Jan Madsen, Anne Altman, and Gayathri Rajan. They oversee the company's strategic direction and operations.

View full answer

Is MAXIMUS, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, MAXIMUS, Inc. is fairly valued with a P/E ratio of 13 and has underperformed the S&P 500 over the past year and three years, suggesting it may not be a compelling investment opportunity at this time.

View full answer

Is MAXIMUS, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, MAXIMUS, Inc. has a mildly bullish technical trend, supported by a positive weekly MACD and Bollinger Bands, although it has underperformed the S&P 500 over the long term despite a recent weekly return of 2.98%.

View full answer

Compare MAXIMUS, Inc. with Similar Stocks

Remitly Global, Inc.Clarivate Plc Bright Horizons Family Solutions, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

High Management Efficiency with a high ROCE of 15.51%

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 41.75

Healthy long term growth as Net Sales has grown by an annual rate of 10.52%

Flat results in Jun 25

With ROCE of 17.51%, it has a fair valuation with a 1.77 Enterprise value to Capital Employed

Mojo Parameters

Stock DNA

Industry

Miscellaneous

Market cap

USD 4,025 Million (Small Cap)

P/E

15.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.83

Return on Equity

21.64%

Price to Book

2.34

Revenue and Profits:

Net Sales:

1,345 Million

(Quarterly Results - Dec 2025)

Net Profit:

94 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-14.24%

6 Months

-19.13%

1 Year

8.33%

2 Years

-13.81%

3 Years

-3.68%

4 Years

-0.84%

5 Years

-17.27%

MAXIMUS, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.41%

EBIT Growth (5y)

13.96%

EBIT to Interest (avg)

41.75

Debt to EBITDA (avg)

2.07

Net Debt to Equity (avg)

0.83

Sales to Capital Employed (avg)

1.69

Tax Ratio

27.61%

Dividend Payout Ratio

21.79%

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

15.51%

ROE (avg)

15.74%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.77

EV to EBIT

11.67

EV to EBITDA

9.47

EV to Capital Employed

1.93

EV to Sales

1.20

PEG Ratio

0.96

Dividend Yield

ROCE (Latest)

16.54%

ROE (Latest)

17.88%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 99 Schemes (64.87%)

Foreign Institutions

Held by 163 Foreign Institutions (18.9%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 2.02% vs -2.22% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 24.70% vs -28.96% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,345.00",
          "val2": "1,318.40",
          "chgp": "2.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "170.40",
          "val2": "160.70",
          "chgp": "6.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.10",
          "val2": "22.40",
          "chgp": "-14.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "93.90",
          "val2": "75.30",
          "chgp": "24.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "102.00%",
          "val2": "93.70%",
          "chgp": "0.83%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is 2.36% vs 8.19% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is 3.94% vs 89.68% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,431.30",
          "val2": "5,306.20",
          "chgp": "2.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "702.00",
          "val2": "627.00",
          "chgp": "11.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "75.60",
          "val2": "82.40",
          "chgp": "-8.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-3.20",
          "chgp": "87.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "319.00",
          "val2": "306.90",
          "chgp": "3.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "104.60%",
          "val2": "92.70%",
          "chgp": "1.19%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

1,345.00

1,318.40

2.02%

Operating Profit (PBDIT) excl Other Income

170.40

160.70

6.04%

Interest

19.10

22.40

-14.73%

Exceptional Items

-0.00

-0.50

100.00%

Consolidate Net Profit

93.90

75.30

24.70%

Operating Profit Margin (Excl OI)

102.00%

93.70%

0.83%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.02% vs -2.22% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 24.70% vs -28.96% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

5,431.30

5,306.20

2.36%

Operating Profit (PBDIT) excl Other Income

702.00

627.00

11.96%

Interest

75.60

82.40

-8.25%

Exceptional Items

-0.40

-3.20

87.50%

Consolidate Net Profit

319.00

306.90

3.94%

Operating Profit Margin (Excl OI)

104.60%

92.70%

1.19%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Sep 2025 is 2.36% vs 8.19% in Sep 2024

Consolidated Net Profit

YoY Growth in year ended Sep 2025 is 3.94% vs 89.68% in Sep 2024

All Annual Results

Company CV

About MAXIMUS, Inc.

MAXIMUS, Inc.

Miscellaneous

MAXIMUS, Inc. provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs. The Health Services segment provides a range of BPS, as well as related consulting services, for state, provincial and national government programs. The Human Services segment provides national, state and local human services agencies with a range of BPS and related consulting services for welfare-to-work, child support, higher education and K-12 special education programs.

Company Coordinates

Company Details

1891 Metro Center Dr , RESTON VA : 20190-5287

Tel: 1 703 25185001 703 2518637

https://www.maximus.com/

Registrar Details